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Abstract
Context: Cucumis prophetarum Linn. (Cucurbitaceae) fruit is used for inflammatory-related
problems and is proved to be possessing anticancer and hepatoprotective effects.
Objective: The present investigation was to study the effect of different fractions of
C. prophetarum on antidiabetic and antioxidant activity.
Materials and methods: Aqueous crude extract (CE) of C. prophetarum fruits was fractionated
into water soluble fraction 1 (F1), chloroform fraction 2 (F2), basic fraction 3 (F3), and neutral
fraction 4 (F4) by acid–base extraction. CE and its fractions at different doses (0.02–0.1mg/mL)
were subjected to antidiabetic (a-amylase and a-glucosidase inhibition assays) and antioxidant
(DPPH, superoxide radical scavenging (SO) and metal chelation) evaluation.
Results: F1 exhibited effective antidiabetic activity (p50.05) with an IC50 value of 20.6 and
59.9mg/mL. The activity decreased in the order of CE4F44F34F2, according to a-amylase
assay, which were the same, with the exception of the rank order of F4 and CE, as the
a-glucosidase assay. Furthermore, F1 (IC50¼ 73 mg/mL) showed better reducing ability than
CE4F44F24F3 (IC50¼ 78–272mg/mL), according to the DPPH assay. In SO and metal chelation
assays, F1 showed the highest activity (IC50¼ 101 and 147 mg/mL), respectively; the activity
decreased in the order of CE4F44F34F2 (IC50¼ 126–469 mg/mL) for SO and 194–944 mg/mL
for metal chelation assay.
Conclusion: The results indicate that F1 possesses potent in vitro antidiabetic and antioxidant
activities.
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Introduction
Cucumis prophetarum L. (Cucurbitaceae), commonly known
as wild cucumber native to Asia and Africa, is mostly a
prostrate or climbing monoecious herb. The fruits are
ellipsoid, echinate, and green with white strips. It is
distributed in the Western Ghats of Coorg region
(Karnataka, India). The family includes about 130 genera
and 800 species of plants and a few active compounds have
been investigated for their hepatoprotective, anti-inflamma-
tory, cardiovascular, and cytotoxic effects (Dhiman et al.,
2012).
Diabetes mellitus (DM) is a heterogeneous metabolic
disorder characterized by chronic hyperglycemia with dis-
turbances in carbohydrate, fat, and protein metabolism
resulting from defects in insulin secretion, insulin action, or
both (WHO, 1999). The International Diabetes Federation
predicts a worldwide increase from 8.3 to 10.1% by the year
2035 (IDF, 2013), of which 80% could be type 2 diabetic
cases. The conventional approach for treating diabetes
includes oral hypoglycemic agents such as sulfonylureas,
biguanides, thiazolidinediones, meglinitides and, a-amylase
and a-glucosidase inhibitors (Rang et al., 2003).
a-Amylase and a-glucosidase, involved in the digestive
system, are responsible for hydrolysis of starch to glucose,
which on absorption enters the blood. The activity of these
enzymes correlates to an increase in post-prandial hypergly-
cemia (PPHG) and control of this PPHG is an important
aspect in the treatment of type 2 diabetes. Compounds like
acarbose, miglitol, and voglibose inhibit these enzymes
causing a delay in carbohydrate digestion, thereby reducing
the rate of glucose absorption and consequently, blunting the
post-prandial plasma glucose rise (Conforti et al., 2005).
Also, these inhibitors exhibit some gastrointestinal side
effects.
In DM, free radicals are formed adversely through glucose
oxidation, non-enzymatic glycation of proteins, and from the
respiratory chain as a result of occasional leakage. This leads
to lipid peroxidation and oxidative degradation of glycated
proteins (Maritime et al., 2003), generating more reactive
oxygen species (ROS). Most of the ROS are scavenged by the
endogenous defense system such as catalase, superoxide
dismutase, and the peroxidase-glutathione system. However,
inefficiency of this system to scavenge free radicals relies on
exogenous antioxidants from natural sources. Antioxidants
from plant source are known to reduce oxidative stress and
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protect the body against free radical-mediated toxicities (Olga
et al., 2003).
Plant species evaluated for antioxidant activity are known
to exhibit antidiabetic effect. Indeed, it is estimated that more
than 400 herbal or plant-derived products are used for the
management of type 2 diabetes across the globe (Balley &
Day, 1989). The hypoglycemic effect of some plant extracts
has been confirmed in human and animal models of type 2
diabetes (Manisha et al., 2007). The WHO Expert Committee
on diabetes has recommended that medicinal plants be further
investigated. Therefore, the study was to determine the
in vitro antidiabetic and antioxidant properties of different
fractions obtained from aqueous extract of C. prophetarum
fruit by using standard methods.
Materials and methods
Materials
Chemicals such as DNSA, ascorbic acid, a-tocopherol, citric
acid, ferrous chloride, ferrozine, trichloroacetic acid, ferric
chloride, Tris, NBT, NADH, PMS, and methanol were
purchased from Himedia Laboratories, Mumbai, India.
DPPH was obtained from Sigma-Aldrich (St. Louis, MO).
a-Amylase, a-glucosidase, soluble starch, and maltose were
procured from SRL Pvt Ltd, Mumbai, India. Glucose assay kit
was purchased from Agappe Diagnostic Pvt Ltd, Kerala, India.
All other chemicals and reagents used were of analytical grade.
Plant material
The fruits of C. prophetarum were collected during July and
August 2011 from Western Ghats of Coorg region
(Karnataka, India) and were authenticated by Prof. M. B.
Shivanna. The herbarium with voucher no. KU/BL/MK/105
has been deposited in Applied Botany Department, Kuvempu
University, Shimoga, India.
Extract preparation
Fresh fruits were washed, cleaned, and air-dried. Whole fruits
(300 g) were homogenized without water in a commercial
blender. The fresh juice was filtered using muslin cloth and
the filtrate was centrifuged at 23 000 g for 10 min, the
supernatant was lyophilized and stored at 20 C until use.
The extract was used at the required concentrations.
Qualitative preliminary phytochemical group test
The tests for carbohydrates, reducing sugars, proteins, amino
acids, saponins, sterols, alkaloids, tannins, glycosides, and
flavonoids content of aqueous extract were performed by
standard methods (Brain & Turner, 1975; Evans, 1996).
Preparation of different fractions
Four different fractions were obtained from aqueous crude
extract of C. prophetarum fruit as shown in Figure 1.
Antidiabetic activity determination
Two methods, a-amylase and a-glucosidase inhibition assays,
were used based on the interaction of different fractions with
the enzymes leading to decreases in the activity.
Pancreatic a-amylase inhibition assay
The inhibition assay was performed using the chromogenic
DNSA method as described by Miller (1959), with slight
modification. The assay mixture composed of 500 mL of
0.02 M sodium phosphate buffer (pH 6.9 containing 6 mM
sodium chloride), 0.25 units of PPA solution, and different
test samples at 0.02, 0.04, 0.06, 0.08, and 0.1 mg/mL (w/v)
concentration were pre-incubated at 37 C for 10 min. To the
above buffer, 500 mL of 1% (w/v) starch solution was added to
each tube and incubated at 37 C for 15 min. The reaction was
terminated with 1.0 mL DNSA reagent, placed in a boiling
water bath for 5 min, cooled to room temperature, diluted, and
the absorbance was measured at 540 nm. The control without
test sample represented 100% enzyme activity. The absorb-
ance produced by CE and its fractions was eliminated by
including appropriate sample control in the reaction mixture
except for the enzyme and starch. The known PPA inhibitor
acarbose was used as a positive control.
a-Glucosidase inhibition assay
This was done according to the method of Andrade–Cetto
with slight modifications (Andrade-Cetto et al., 2008). The
assay was carried out by incubating a solution of starch
substrate (2% w/v maltose) 1 mL of 0.2 M Tris buffer pH 8.0
and various concentrations of different test samples for 5 min
at 37 C. The reaction was initiated by adding 1 mL of
a-glucosidase enzyme (1 U/mL) followed by incubation for
10 min at 37 C. The reaction mixture was heated for 2 min in
a boiling water bath to stop the reaction. The quantity of
glucose liberated was measured using GOD-POD kit (Sigma-
Aldrich, St. Louis, MO). The control represented 100%
enzyme activity and did not contain any test sample. The
absorbance produced by test sample was eliminated by
including appropriate sample controls in the reaction mixture
except for the enzyme and substrate. The a-glucosidase
inhibitor, acarbose, was used as a positive control.
Calculation of IC50 value of antidiabetic assay
The IC50 values were defined as the concentration of the
extract, containing the enzyme inhibitor that inhibited the
activity by 50%.
The % of inhibition was calculated as follows:
% Inhibition ¼ EC  ET  TCð Þ=EC
where EC is the enzyme activity of control, ET is the enzyme
activity of test, and TC is the test control.
One unit of enzyme activity is defined as the amount of
enzyme required to release one micromole of product from
substrate per min under the assay conditions.
Antioxidant activity determination
Three methods, DPPH, superoxide radical scavenging, and
metal chelation, were used based on the reaction with
electron-donating or metal chelating antioxidants.
DPPH assay
The DPPH free radical-scavenging activity of each sample
was determined (Lai et al., 2001). An aliquot of 200 mL of
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each sample with different concentrations (0.02, 0.04, 0.06,
0.08, and 0.1 mg/mL) were mixed with 100 mM Tris-HCl
buffer (800mL, pH 7.4) and then added to 1 mL of 500 mM
freshly prepared DPPH solution in ethanol (a final concen-
tration of 250 mM). The mixture after shaking vigorously was
allowed to stand for 20 min at room temperature in dark and
the absorbance was measured at 517 nm. Ascorbic acid was
used as a standard.
Superoxide radical-scavenging assay
The activity was measured as described by Robak and
Gryglewski (1998). The superoxide anion radicals were
generated in 3.0 mL of Tris-HCl buffer (16 mM, pH 8.0),
containing 0.5 mL NBT (0.3 mM), 0.5 mL NADH (0.936 mM)
solution, 1.0 mL extract, and 0.5 mL Tris-HCl buffer (16 mM,
pH 8.0). The reaction was started by adding 0.5 mL PMS
solution (0.12 mM) to the mixture, incubated at 25 C for
5 min, and the absorbance was read at 560 nm against a blank.
Ascorbic acid was used as a positive control.
Metal chelation assay
The effect of chelation of ferrous ions on each sample was
estimated using the method of Dinis et al. (1994). To 0.1 mL
of the extract, a solution of 0.5 mL ferrous chloride (0.2 mM)
was added. The reaction was initiated by adding 0.2 mL of
ferrozine (5 mM), incubated at room temperature for 10 min,
and the absorbance was measured at 562 nm. Citric acid was
used as a positive control.
Calculation of IC50 value of antioxidant assay
The concentration of sample required for scavenging 50% of
the radicals/to chelate metal ions was calculated as follows.
% Inhibition ¼ Acont  Asamp
 
Acont
  100
where ‘‘Acont’’ is the absorbance of control, and ‘‘Asamp’’ is
the absorbance of sample. IC50 values denote the concentra-
tion of a sample required to decrease the absorbance by 50%.
Statistical analysis
Values in tables and graphs were means ± standard deviations
(n¼ 3). The IC50 values were calculated from linear regres-
sion analysis. Statistical comparisons were performed by one-
way analysis of variance (ANOVA) followed by Student’s
t-test to determine the significant difference between samples
with 95% confidence limit.
Results and discussions
Preparation of crude extract and its fractions from
C. prophetarum and screening of phytochemicals
The crude extract was fractionated to obtain four fractions.
Fraction 1 (F1) was isolated by precipitation and an acid–base
Figure 1. Schematic diagram of fractionation
of aqueous extract of C. prophetarum fruits.
CHCl3 : MeOH
 
Evaporated and dried 
Basic fraction (F3)
(0.74%)
Aqueous basic layer
neutralized with 5% H2SO4 
Evaporated and dried 
Neutral fraction (F4)
(59.54%)
CHCl3 extract
Evaporated and dried 
CHCl3 fraction (F2)
(1.17%)
Aqueous acid layer, Basified using
5% NaOH (pH 10.0) and extracted
twice using CHCl3 : MeOH (3:1)
White precipitate Clear supernatant (Pale yellow color) 
Evaporated and dried 
Evaporated to 1/10 vol (< 40°C),
acidified to pH 2.0 using 5% H2SO4
& extracted with CHCl3 (x2)
Water soluble fraction (F1)
(35.58%)
Crude aqueous extract (CE) 
Methanol addition (x2) & centrifugation at 5000 rpm for 5 min 
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extraction was carried out to obtain fraction 2 (F2), fraction 3
(F3), and fraction 4 (F4). The separation was based on pH
with the use of different solvents that influence their solubility
in either of one solvent based on the acidic, basic, or neutral
nature. The total recovery from four fractions was 97.03% and
the residual 2.97% was lost in extraction process. The
recoveries of F1, F2, F3, and F4 were 35.58, 1.17, 0.74, and
59.54%, respectively. Phytochemical analysis of crude extract
revealed the presence of carbohydrates, reducing sugars,
amino acids, saponins, and sterols. F1 showed positive result
for amino acid test and glycosides.
Antidiabetic activity
DM is probably the fastest growing metabolic disease,
wherein type 2 diabetes accounts for 9% of deaths worldwide
and as knowledge about the heterogeneous nature of the
disease increases, so does the need for more challenging and
appropriate therapies. The aim of oral therapy is to reach
normoglycemia to prevent later complications. Among glu-
cose-lowering medications, a-amylase and a-glucosidase
inhibitors delay the absorption of ingested carbohydrates,
reducing the postprandial glucose and insulin peaks.
Polysaccharide starch and disaccharides such as sucrose and
lactose are the main source of glucose in human diet. Starch is
initially broken down to oligosaccharides by a-amylase
present in the saliva and pancreatic juice. The pancreatic
form released into the small intestine is more potent than the
salivary enzyme, and contact with these enzymes results in
almost total conversion of starch to disaccharide maltose and
other very small glucose oligomers before it leaves the
duodenum (Guyton & Hall, 2000). a-Glucosidase is a
collective term referring to membrane-bound enzymes of
the small intestinal villi involved in the breakdown of
a-linkages of oligosaccharides and disaccharides into glucose.
Monosaccharides; glucose, fructose, and galactose are the
final products of carbohydrate digestion. Normally, mono-
saccharides released by digestion are rapidly absorbed in the
first half of the small intestine. However, digestion occurs
throughout the small intestine, in the presence of inhibitors,
resulting in slower absorption of monosaccharides and
blunting of the postprandial glucose rise (Rhabasa-Lhoret &
Chiasson, 2004). A search for compounds that can inhibit
these intestinal enzymes is therefore regarded as one of the
therapeutic approaches for developing novel antidiabetic
agents (Lebovitz, 1992).
Recent advances in understanding the activity of these
intestinal enzymes have led to the development of newer
pharmacological agents. In this study, in vitro inhibitory effect
of different fractions of C. prophetarum on porcine pancreatic
amylase and intestinal a-glucosidase was evaluated based on
chromogenic DNSA and glucose oxidase peroxidase methods,
respectively (Figure 2). F1 exhibited effective inhibition of
a-amylase and a-glucosidase with an IC50 value of 20.6 and
59.9mg/mL, respectively, and showed a dose-dependent effect
on increasing the concentration. Acarbose used as a positive
control showed an IC50 value of 32.98 mg/mL for a-amylase
and 33.6 mg/mL for a-glucosidase, under similar assay
conditions. F4 (IC50¼ 95 mg/mL) showed less inhibition of
a-amylase when compared with CE (IC50¼ 85 mg/mL).
Whereas, for a-glucosidase, F4 with an IC50 value of
78 mg/mL showed better inhibition than CE (IC50¼ 132 mg/
mL). In both the assays, F2 showed the least inhibition when
compared with F3 (Table 1).
Antioxidant activity
Recent experiments and clinical studies have uncovered new
insights into the role of oxidative stress in diabetic compli-
cations and these reports have demonstrated different and
innovative approaches to employ natural, antioxidant thera-
pies. Various plant species have been evaluated for antioxi-
dant activities which have also shown to exhibit antidiabetic
activity (Kavishankar et al., 2011).
Antioxidants are compounds that prevent the oxidation of
essential biological macromolecules by inhibiting the
0
10
20
30
40
50
60
70
80
90
100
(A)
(B)
0 0.02 0.04 0.06 0.08 0.1
α
-
A
m
yl
as
e 
in
hi
bi
tio
n 
ra
te
 (%
)
Concentration in mg/mL
0 0.02 0.04 0.06 0.08 0.1
Concentration in mg/mL
CE F1 F2 F3 F4 STD
0
10
20
30
40
50
60
70
80
90
100
α
-
G
lu
co
sid
as
e 
in
hi
bi
tio
n 
ra
te
 (%
)
CE F1 F2 F3 F4 STD
Figure 2. Antidiabetic activity of crude extract and its fractions from
C. prophetarum as determined by a-amylase inhibition assay (A) and
a-glucosidase inhibition assay (B).
Table 1. Antidiabetic activity of CE and its fractions of C. prophetarum
as determined by a-amylase and a-glucosidase inhibition assay.
Sample IC50/a-amylase (mg/mL) IC50/a-glucosidase (mg/mL)
CE 85.17 ± 1.4* 132.28 ± 5.52*
F1 20.66 ± 1.41** 59.91 ± 0.54*
F2 715.27 ± 6.37*** 410.31 ± 5.73***
F3 542.88 ± 2.57*** 336.14 ± 0.06***
F4 95.71 ± 0.69* 78.03 ± 1.97*
Acarbose 32.98 ± 3.46 33.66 ± 0.99
Values are mean ± SD (n¼ 3). Values not sharing a common superscript
letter differ significantly at p50.05 when compared with the standard
acarbose. The IC50 values were evaluated as the concentration of the
test sample required to inhibit the activity by 50% under assayed
condition.
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propagation of the oxidizing chain reaction. Keeping in mind
the adverse effects of synthetic antioxidants, researchers have
channeled their interest in isolating natural antioxidants (Kuo
et al., 2005), which are very effective to control the oxidative
stress and hence prevent the initiation of disease propagation.
One important mechanism of antioxidation is scavenging of
reactive oxygen species (ROS). ROS have various forms of
activated oxygen, which include free radicals such as
superoxide anion radicals (O2), hydroxyl radicals (OH),
non-free radicals (H2O2), and singlet oxygen (Halliwell,
1995). The stable radical DPPH has been used widely for the
determination of primary antioxidant activity (Goncalves
et al., 2005).
DPPH is one of the compounds that possess a proton free
radical with a characteristic absorption, which decreases
significantly on exposure to proton radical scavengers and
gets converted to 1,1-diphenyl-2-picryl hydrazine. In the
present investigation, the effect of CE and its fractions are
shown in Figure 3(A). Five different concentrations were used
for each sample. F1 exhibited higher scavenging activity
(IC50¼ 73 mg/mL) than CE, F4, F2, and F3, where the IC50
values ranged from 78 to 272 mg/mL (Table 2), but was less
compared with ascorbic acid that showed maximum activity
with an IC50 value of 59.95 mg/mL. The free radical
scavenging activity of crude extract was much more than
F4, as this could be due to the presence of F1 in it. The greater
free radical-scavenging activity corresponds to lower IC50
values.
Superoxides are radicals in which the unpaired electron is
located on oxygen. They can generate more highly reactive
hydroxyl radicals and protonated form of superoxide
(Halliwell & Chirico, 1993). The strongest reactive oxygen
species are derived from free amino groups that can react with
hydroxyl radical or the NH2+ groups can form NH3+
subsequently reacting with hydroxyl radical through addition
reaction (Xue et al., 1998). The more free amino groups
present, higher will be the scavenging effect towards DPPH
radicals and superoxide anion radicals. In the study, the IC50
values of CE, its fractions and standards were determined;
ascorbic acid and citric acid were compared, which revealed
F1 to be more potent (Figure 3B) with an IC50 value of 101
and 147 mg/mL for superoxide radical scavenging and metal
chelation assay, respectively. Whereas IC50 values of stand-
ards, ascorbic acid and citric acid, CE, F4, F3, and F2 were in
the range of 112–469 mg/mL for SO, in which, F2 showed
least inhibition (Table 2). Superoxide anion, hydrogen
peroxide, and hydroxyl radical contribute to the pathogenesis
of a variety of diseases. They are generated in vivo by
mechanisms such as, respiratory redox chain in mitochondria,
the respiratory burst of phagocytes, and the activities of
various oxidases. Although superoxide anion is by itself a
weak oxidant, it gives rise to the powerful and dangerous
hydroxyl radicals as well as singlet oxygen both of which
contribute to oxidative stress (Dahl & Richardson, 1978;
Meyer & Isaksen, 1995; Pietta, 2000). Therefore, superoxide
radical scavenging by antioxidants has physiological
implications.
Ferrozine quantitatively complexes with Fe2+. This com-
plex formation is disrupted in the presence of chelating agents
resulting in decrease of red color complex formation.
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Figure 3. Antioxidant activity of crude extract and its fractions from C. prophetarum as determined by the DPPH free radical-scavenging assay (A),
superoxide radical scavenging assay (B), and metal chelation assay (C).
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Therefore, the color reduction estimates the chelating activity
of the coexisting chelator. The antioxidant abilities of CE and
its fractions determined by the metal chelation method are
shown in Figure 3(C). The chelating effect on Fe2+ and
ferrozine complex formation is shown in Table 2. The highest
metal chelating rate was found for F1 (IC50¼ 147 mg/mL),
when compared with standard citric acid (IC50¼ 168 mg/mL).
F1 interfered with the complex formation, suggesting that it
has chelating activity and complexes with ferrous ion before
ferrozine to overcome ROS generation. Here, F4 showed less
chelation compared with CE, which was followed by F2
that showed the least activity with an IC50 value ranging from
194 to 944mg/mL.
Conclusions
In vitro antidiabetic activity of CE and its four fractions
of water extract were determined by a-amylase and
a-glucosidase inhibition assays and their antioxidant activities
were assessed by DPPH, SO, and metal chelation methods.
It was found that F1 showed potent antidiabetic and antioxi-
dant activities. The results provide useful information on
pharmacological activities of this plant associated with
diabetes.
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Table 2. Antioxidant activity of CE and its fractions of C. prophetarum
as determined by DPPH, SO, and metal chelation assays.
Sample
IC50/DPPH
(mg/mL)
IC50/SO
(mg/mL)
IC50/metal chelation
(mg/mL)
CE 78 ± 0.64* 126 ± 2.42* 194 ± 5.55***
F1 73 ± 0.64** 101 ± 1.08** 147 ± 2.85**
F2 255.84 ± 1.14*** 469.55 ± 9.43*** 857.74 ± 9.48***
F3 272.80 ± 2.44*** 338.90 ± 2.66*** 944.3233 ± 18.14***
F4 112 ± 4.93* 198 ± 1.21* 468 ± 2.77*
Standard 59.95 ± 0.66a 112 ± 3.97a 168 ± 5.31b
Values are mean ± SD (n¼ 3). Values not sharing a common superscript
letter differ significantly at p50.05 when compared with the standard
acarbose. The IC50 values were evaluated as the concentration of the
test sample required to decrease the absorbance by 50% under assayed
condition.
aAscorbic acid used as a standard.
bCitric acid used as a standard.
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